Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer Journal Articles uri icon

Overview

Published in

  • Blood

Time

Date/time value

  • 1997

Additional Document Info

Parent Title

  • BLOOD

Volume

  • 89

Issue

  • 9

Publisher

  • American Society of Hematology